Current Research

The goal of these studies is to improve the accuracy of the early diagnosis of Alzheimer's Diesease (AD) and to identify markers for individuals who may be at risk for developing AD. We are now testing an early screen, using brain measurements from Magnetic Resonance Imaging (MRI) in combination with the analysis of certain brain derived proteins in cerebrospinal fluid (CSF), the fluid surrounding and cushioning the brain and spinal cord. By testing CSF for these proteins and correlating these results with results from brain MRI scans and cognitive tests, we believe we will be able to accurately diagnose AD early in its course. This has the potential to target early intervention.

How You Can Help

The information gained from these studies will help the investigators develop an early screening panel for AD.

Benefits of Participating

• All procedures are done at no cost to participants
• Complete medical and neurological exams and laboratory tests
• Comprehensive memory testing
• LP procedure
• MRI scan of the brain
• Upon completion of the study, participants will be compensated $250.00 for each time-point ($200.00 plus $50.00 traveling expenses)

Eligibility

• Men and Women between the ages of 40-60 years old
• Completion of high school
• No significant memory complaints
• No history of familial early onset dementia

Time & Requirements

The total time required is 3-4 visits.

For additional information regarding this study, click here or contact Kenneth E. Rich at (212) 263-7563.

How can you participate?

You can access the application with the link below. Once you have filled out the application, it can be emailed to Kenneth E. Rich, or mailed to:

ATTN: Kenneth E. Rich
New York University School of Medicine
Department of Psychiatry
Center for Brain Health
550 First Avenue, MHL-400
New York, NY 10016

Click here for Application